Long‐term proton pump inhibitor use and risk of osteoporosis and hip fractures: A nationwide population‐based and multicenter cohort study using a common data model.

MLA

Park, Da Hee, et al. “Long‐term Proton Pump Inhibitor Use and Risk of Osteoporosis and Hip Fractures: A Nationwide Population‐based and Multicenter Cohort Study Using a Common Data Model.” Journal of Gastroenterology & Hepatology, vol. 37, no. 8, Aug. 2022, pp. 1534–43. EBSCOhost, https://doi.org/10.1111/jgh.15879.

APA

Park, D. H., Seo, S. I., Lee, K. J., Kim, J., Kim, Y., Seo, W., Lee, H. S., Shin, W. G., & Yoo, J. J. (2022). Long‐term proton pump inhibitor use and risk of osteoporosis and hip fractures: A nationwide population‐based and multicenter cohort study using a common data model. Journal of Gastroenterology & Hepatology, 37(8), 1534–1543. https://doi.org/10.1111/jgh.15879

Chicago

Park, Da Hee, Seung In Seo, Kyung Joo Lee, Jinseob Kim, Yerim Kim, Won‐Woo Seo, Hyung Seok Lee, Woon Geon Shin, and Jong Jin Yoo. 2022. “Long‐term Proton Pump Inhibitor Use and Risk of Osteoporosis and Hip Fractures: A Nationwide Population‐based and Multicenter Cohort Study Using a Common Data Model.” Journal of Gastroenterology & Hepatology 37 (8): 1534–43. doi:10.1111/jgh.15879.